INSTITUTIONAL SUBSCRIPTIONS
Typically, an institutional subscription works through IP verification, which eliminates the need to sign in with a username and password. Access is swift and unencumbered, and all we need is your IP address.
We will work with you to announce your free trial to your faculty and staff. At the end of your trial period, we provide you with the usage statistics. There is no obligation.
Pricing
All institutional subscriptions are priced according to the size of the organization. You will be credited for any existing subscriptions within your institution. Contact Paul Goldberg, editor and publisher for more information.
Institutional Subscribers
The Cancer Letter has over 120 institutional subscribers in the U.S. and abroad.
Here is a partial list:
American Cancer Society American Society of Clinical Oncology Baylor College of Medicine Cancer Treatment Centers of America Carolinas Healthcare City of Hope Cleveland Clinic Cancer Center Eli Lilly & Co. Emory University Winship Cancer Institute Food & Drug Administration Fox Chase Cancer Center Fred Hutchinson Cancer Research Center Genentech Georgetown University Lombardi Cancer Center Harvard Medical School/Dana-Farber/MGH H. Lee Moffitt Cancer Center Mallinckrodt The Mayo Clinic MD Anderson Cancer Center Divisions Memorial Sloan-Kettering Cancer Center National Cancer Institute New York University Northwestern University Norton Healthcare |
Novartis The Ohio State University Pfizer Roche Roswell Park Sanofi Sanford-Burnham Medical Research Institute Seattle Cancer Care Alliance St. Jude Children's Research Hospital Universidad de Granada University of California, San Francisco University of California, San Diego University of Chicago University of Colorado at Denver University of Illinois Cancer Center University of Kentucky Markey Cancer Center University of Maryland Greenebaum Cancer Center University of Michigan Cancer Center University of North Carolina, Chapel Hill University of Pennsylvania University of Pittsburgh Cancer Center U.S. Army Medical Research & Materiel Command Vanderbilt-Ingram Cancer Center |